Location History:
- Cook, IL (US) (2000)
- Marlboro, MA (US) (2003)
- Ann Arbor, MI (US) (2004)
- Chicago, IL (US) (1997 - 2005)
- Philadelphia, PA (US) (2006)
- Merion, PA (US) (2006 - 2014)
- Merion Station, PA (US) (2008 - 2015)
Company Filing History:
11 out of 3,385 
9 out of 16,083 
8 out of 389 
Years Active: 1997-2015
Title: Innovator Spotlight: Craig B. Thompson
Introduction
Craig B. Thompson, a prominent inventor based in Merion, PA, has made significant contributions to the field of cancer treatment through his innovative work. With a remarkable portfolio of 32 patents, Thompson's research focuses on developing methods and compositions aimed at effectively treating cancer.
Latest Patents
Among his latest patents, Thompson has disclosed several groundbreaking methods related to cancer treatment. These include:
- Compositions and methods for treating individuals identified as having cancer using ATP citrate lyase inhibitors and/or tricarboxylate transporter inhibitors. The inventions outline methods for inducing apoptosis in cancer cells using these inhibitors.
- Specific treatment methodologies for individuals diagnosed with cancer, which involve identifying the cancer's high rate of aerobic glycolysis and administering the necessary inhibitors.
- Innovative methods to identify compounds with anticancer activity, enhancing the development of new therapeutic agents.
- Thompson has also focused on the single diastereomers of 4-fluoroglutamine, describing their preparation and use as imaging agents, crucial in diagnosing and treating cancer effectively.
Career Highlights
Craig B. Thompson's career is marked by his impactful research and dedication to advancing cancer therapies. He has worked with renowned institutions such as the University of Michigan, further enhancing his expertise and contributions to medical science. His relentless pursuit of innovation has earned him a prominent place among inventors in the biomedical field.
Collaborations
Throughout his career, Thompson has collaborated with notable colleagues, including Carl H. June and Gary J. Nabel. These partnerships have been instrumental in fostering new ideas and enhancing his research initiatives, ultimately leading to the development of several pioneering treatments for cancer.
Conclusion
Craig B. Thompson's continued endeavors in cancer research exemplify the spirit of innovation. Through his substantial number of patents and collaborations, he demonstrates a commitment to improving healthcare outcomes. His work not only advances cancer treatment but also inspires future generations of inventors and researchers in the biomedical field.